Retinal Vascularization Rate Predicts Retinopathy of Prematurity and Remains Unaffected by Low-Dose Bevacizumab Treatment.

Abstract

Authors

• Emer Chang
  From the Oxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust (E.C., A.J., R.P., S.A.A., C.K.P., K.X.), Oxford, UK.
• Amandeep Josan
  From the Oxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust (E.C., A.J., R.P., S.A.A., C.K.P., K.X.), Oxford, UK; Nuffield Laboratory of Ophthalmology, Nuffield Department of Clinical Neurosciences, University of Oxford (A.J., K.X.), Oxford, UK.
• Ravi Purohit
  From the Oxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust (E.C., A.J., R.P., S.A.A., C.K.P., K.X.), Oxford, UK.
• Sher A Aslam
  From the Oxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust (E.C., A.J., R.P., S.A.A., C.K.P., K.X.), Oxford, UK.
• Caroline Hartley
  Department of Paediatrics University of Oxford Oxford UK.
• Chetan K Patel
  From the Oxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust (E.C., A.J., R.P., S.A.A., C.K.P., K.X.), Oxford, UK.
• Kanmin Xue
  Nuffield Department of Neuroscience, Oxford University, Oxford, UK.

Keywords

External Resources